Child cancer survivor advocates for equal access to experimental treatments

News | JESSE CNOCKAERT
Published: Thursday, 12/13/2018 4:56 pm EST
Last Updated: Monday, 12/17/2018 4:55 pm EST

Prime Minister Justin Trudeau met with Helena Kirk in 2017 during her visit to Ottawa. The 12-year-old Toronto cancer-survivor is advocating for support in the federal budget towards equal access to experimental cancer therapies for children. She returned to Ottawa this Dec. 12 to speak with Health Canada and the Canadian Institutes of Health Research. (Photo courtesy of Sarah Calderwood).

To View the rest of this article, please choose one of the following

If you are already a subscriber

Subscribe to The Lobby Monitor

Sign Up for a free trial

For instant access to the website.

On Queen Street: New independent shop aims to make GR accessible to marginalized groups
Dec. 13, 2024 12:00 am.
VIEW
Industry lobbyists prepare for second round of Trump trade policy
Dec. 12, 2024 12:00 am.
VIEW
‘It’s not just about wildfires’: Canada’s fire chiefs advocate for National Fire Administration and federal funding
Dec. 11, 2024 12:00 am.
VIEW
Communication Reports: Dec. 2, 2024, to Dec. 8, 2024
Dec. 10, 2024 12:00 am.
VIEW
Several energy and natural resources companies join registry
Dec. 09, 2024 12:00 am.
VIEW

SEE A SAMPLE

READY TO SUBSCRIBE?

Lobby Monitor Subscribers receive:

·
Analysis of Lobbying campaigns and the people behind them
·
Detailed Reports on Lobby Registry activity in an easy to read format
·
Profiles of Key players in the industry in Ottawa and Washington
·
Best Practices and insider tips

These key people read the Lobby Monitor and make decisions that could affect your business:

·
Company CEOs, senior executives who hire GR specialists
·
Law firms and GR firms

·
Public Relations specialists

·
Executives and senior staff

·
Industry and association professionals

·
Academics, researchers and advisers

·
Canadian government leaders, policy experts and senior bureaucrats

·
Provincial government and senior bureaucrats

For more information about The Lobby Monitor, click here or call 613.688.8822.

Child cancer survivor advocates for equal access to experimental treatments

To View the rest of this article, please choose one of the following

If you are already a subscriber

Subscribe to The Lobby Monitor

Sign Up for a free trial

Inside The Lobby Monitor

Subscribers

More Info

Hill Times Publishing

Username
Password